Description
Pre-made inducible lentiviral particles for expressing human target: LMNA (alternative name: RP11-54H19.1, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1), 100% matched CDS region in NCBI ID: NM_005572.3.
Full sequence verified target is natively expressed under a tetracycline inducible suCMV promoter. A blasticidin-RFP fusion marker under RSV promoter, allows to sort or select transduced cells for long term expression via RFP signal or via blasticidin antibiotic (Dual markers). RFP signal provides a convenient, realtime monitoring the particles performance. Each particles was validated in lot by lot basis and target expression is guaranteed. Particles were packaged in serum-free solution containing no any human or animal origin components. See product manual for details (.pdf).
Amount: 200ul, at 1 x 107 IFU/ml in serum-free medium.
Cat#: LVP174
